248 related articles for article (PubMed ID: 11561758)
1. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
[TBL] [Abstract][Full Text] [Related]
3. Correlations between the expression of hTERT and α and β splice variants in human brain tumors.
Khajehgoodari R; Khorvash F; Kheirollahi M; Mirsafaie M; Salehi M
Adv Clin Exp Med; 2019 Apr; 28(4):507-513. PubMed ID: 31044567
[TBL] [Abstract][Full Text] [Related]
4. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
[TBL] [Abstract][Full Text] [Related]
5. Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Falchetti ML; Pallini R; Larocca LM; Verna R; D'Ambrosio E
J Clin Pathol; 1999 Mar; 52(3):234-6. PubMed ID: 10450187
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
Maes L; Kalala JP; Cornelissen R; de Ridder L
Anticancer Res; 2006; 26(3B):2295-300. PubMed ID: 16821605
[TBL] [Abstract][Full Text] [Related]
7. Telomerase in intracranial meningiomas.
Boldrini L; Pistolesi S; Gisfredi S; Ursino S; Lupi G; Caniglia M; Pingitore R; Basolo F; Parenti G; Fontanini G
Int J Mol Med; 2003 Dec; 12(6):943-7. PubMed ID: 14612971
[TBL] [Abstract][Full Text] [Related]
8. Progression of astrocytomas and meningiomas: an evaluation in vitro.
Maes L; Kalala JP; Cornelissen M; de Ridder L
Cell Prolif; 2007 Feb; 40(1):14-23. PubMed ID: 17227292
[TBL] [Abstract][Full Text] [Related]
9. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme.
Falchetti ML; Pallini R; D'Ambrosio E; Pierconti F; Martini M; Cimino-Reale G; Verna R; Maira G; Larocca LM
Int J Cancer; 2000 Dec; 88(6):895-901. PubMed ID: 11093811
[TBL] [Abstract][Full Text] [Related]
10. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
[TBL] [Abstract][Full Text] [Related]
11. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
12. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
13. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
14. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Am J Pathol; 2003 Mar; 162(3):1019-26. PubMed ID: 12598334
[TBL] [Abstract][Full Text] [Related]
15. Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.
Chen HJ; Liang CL; Lu K; Lin JW; Cho CL
Cancer; 2000 Nov; 89(10):2092-8. PubMed ID: 11066050
[TBL] [Abstract][Full Text] [Related]
16. Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
Kotoula V; Barbanis S; Nikolakaki E; Koufoyannis D; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2004 May; 107(5):443-51. PubMed ID: 14986029
[TBL] [Abstract][Full Text] [Related]
17. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
18. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
19. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
Kyo S; Kanaya T; Takakura M; Tanaka M; Inoue M
Int J Cancer; 1999 Jan; 80(1):60-3. PubMed ID: 9935231
[TBL] [Abstract][Full Text] [Related]
20. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
